ClinicalTrials.gov
ClinicalTrials.gov Menu

Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01295073
Recruitment Status : Withdrawn (appropriate study medication supply could not be identified)
First Posted : February 14, 2011
Last Update Posted : May 9, 2018
Sponsor:
Information provided by (Responsible Party):
David Maberley, University of British Columbia

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given